Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release

Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Takenaka, Kenchi, Nishitani, Rie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509896/
https://www.ncbi.nlm.nih.gov/pubmed/31110729
http://dx.doi.org/10.1002/ccr3.2139
_version_ 1783417342717329408
author Takenaka, Kenchi
Nishitani, Rie
author_facet Takenaka, Kenchi
Nishitani, Rie
author_sort Takenaka, Kenchi
collection PubMed
description Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐LAR may be considered for use in carefully selected elderly individuals.
format Online
Article
Text
id pubmed-6509896
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65098962019-05-20 Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release Takenaka, Kenchi Nishitani, Rie Clin Case Rep Case Reports Two elderly patients with poorly controlled type 2 diabetes mellitus had difficulty self‐managing their medications. Exenatide long‐acting release (LAR), with an extended administration interval of 1 month, maintained hemoglobin A1c (HbA1c) level in the 7% range. Monthly administration of exenatide‐LAR may be considered for use in carefully selected elderly individuals. John Wiley and Sons Inc. 2019-04-07 /pmc/articles/PMC6509896/ /pubmed/31110729 http://dx.doi.org/10.1002/ccr3.2139 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Takenaka, Kenchi
Nishitani, Rie
Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title_full Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title_fullStr Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title_full_unstemmed Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title_short Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
title_sort two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509896/
https://www.ncbi.nlm.nih.gov/pubmed/31110729
http://dx.doi.org/10.1002/ccr3.2139
work_keys_str_mv AT takenakakenchi twocasesoftype2diabetesmellitusinelderlypatientssuccessfullytreatedwithmonthlyexenatidelongactingrelease
AT nishitanirie twocasesoftype2diabetesmellitusinelderlypatientssuccessfullytreatedwithmonthlyexenatidelongactingrelease

Ejemplares similares